Innovative Eyewear, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023; comparison with FY2022. The company develops and sells smart eyewear, primarily Lucyd Lyte glasses, through e-commerce and retail partners. Its products are designed in the U.S. and manufactured in Asia.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue, audited financial statements | $1.152 million | $660,000 |
| Cost of goods sold | $1.272 million | $716,000 |
| Gross profit (loss) | $(119,000); approximately (10.4%) margin | $(56,000); approximately (8.5%) margin |
| Operating expenses | $6.736 million | $5.520 million |
| Net loss | $(6.663) million | $(5.682) million |
| Basic and diluted loss per share | $(0.63) | $(0.87) |
| Cash used in operating activities | $(5.766) million | $(3.224) million |
| Cash and cash equivalents at year-end | $4.287 million | $3.591 million |
- Revenue grew about 75% year over year, while net loss increased about 17%. Operating expenses rose 22%, chiefly from higher general and administrative and research and development costs; sales and marketing expense was broadly flat.
- Year-end current assets were $5.617 million and current liabilities $624,000, implying working capital of about $4.992 million. Total liabilities were $660,000. No related-party convertible debt remained outstanding at December 31, 2023.
- Financing cash inflows were $6.661 million, including net proceeds of $4.116 million from a June 2023 public offering and proceeds from warrant exercises. The offering and warrant exercises increased the share count; 12.917 million common shares were outstanding at year-end.
Business developments and outlook
- FY2023 launches included Lucyd Lyte 2.0 and Lyte XL. The company reported approximately 350 retail stores carrying its products, over 300 wholesale accounts, and more than 20,000 cumulative online orders since inception.
- Management expects growth in both wholesale and e-commerce sales in 2024, further retailer distribution, and launches of Eddie Bauer and Reebok collections. Nautica Powered by Lucyd launched in January 2024. The company anticipates improved gross profit in 2024, citing scale and expected larger orders, but provides no quantified revenue or earnings guidance.
- Management says it aims to achieve profitability within two years, while warning that operating losses may continue. It expects existing cash, warrant proceeds, and planned financing activities to fund operations through at least the end of March 2025. The auditor’s report includes a going-concern emphasis because of recurring losses and negative operating cash flows.
- Minimum royalty payments under the Nautica, Eddie Bauer, and Reebok licenses total $14.171 million through 2032, including $161,210 due in 2024. These agreements also require royalties based on sales.
Risks, contingencies, and unusual items
- Nasdaq listing: The company received a minimum-bid-price deficiency notice in August 2023 and an extension to July 30, 2024 to regain compliance.
- Financial reporting controls: Management concluded disclosure controls and internal control over financial reporting were ineffective at year-end, citing material weaknesses including inadequate segregation of duties and weaknesses in revenue recognition controls. The auditor did not attest to internal control effectiveness.
- Patent dispute: An ITC investigation related to alleged patent infringement was instituted in December 2023. The matter was settled in January 2024 through a multi-year, non-exclusive patent license; the company recorded an approximately $103,000 liability at year-end.
- Related-party financing and transactions: In March 2024, the company issued Lucyd Ltd. a convertible note facility of up to $1.25 million at 10% interest, convertible at Lucyd Ltd.’s discretion; no amount had been borrowed as of the filing. A separate £600,000 loan to an affiliate was repaid in March 2024. Lucyd Ltd. owns approximately 40% of the company, and the company also pays Tekcapital affiliates management and rent expenses.
- Other key exposures: The company depends on sales of a single product line, a limited number of manufacturers and logistics providers, and manufacturing in China. It also faces competition from larger, better-resourced companies, customer-acquisition and return risks, privacy and cybersecurity exposure, and potential dilution or financing constraints.
Important facts for investors to verify
- Reconcile inconsistent FY2023 figures in the filing: audited statements report revenue of $1,152,479, cost of goods sold of $1,271,808, gross deficit of $119,329, and net loss of $6,663,428. Elsewhere, MD&A gives revenue of $1,167,479, cost of goods sold of $1,240,171, and gross deficit of $72,692; a risk-factor passage gives net loss of $6,616,791.
- Track cash burn, financing needs, warrant exercises, dilution, and progress toward the stated liquidity runway and profitability objective.
- Confirm Nasdaq bid-price compliance and remediation of the disclosed material weaknesses in financial reporting controls.
- Assess sales, margins, and cash obligations from the licensed collections against the $14.171 million minimum royalty commitment.
- Monitor retailer onboarding, product returns and quality, and outcomes of the newly licensed patent portfolio and related-party arrangements.